Bigfoot hires three, primes expansion
By HME News Staff
Updated 12:24 PM CST, Thu December 16, 2021
MILPITAS, Calif. – Bigfoot Biomedical, a company dedicated to better health outcomes for people with insulin-requiring diabetes, announced three senior hires with deep experience in the diabetes and health care sectors. Matthew Clemente joins Bigfoot as senior vice president of development; Robin A. Beadle joins as vice president of marketing; and Scott Snead joins as vice president of national accounts. All three positions are new to the company as it moves to expand access to its Bigfoot Unity Diabetes Management Program. “This year was pivotal for our company with Food and Drug Administration clearance of our Bigfoot Unity System followed quickly by commercialization,” said Jeffrey Brewer, CEO. “After quickly contracting with clinics in seven states across the U.S., we are now primed to expand availability to more diabetes centers and endocrinology practices, as well as targeting key health systems. Our aim is to transform the standard of care for the millions of people with diabetes on insulin therapy. At the same time, we have a portfolio of assets that we’ll be developing as we continue to make inroads into the commercial marketplace with our innovative insulin delivery solutions.”
Comments